CareDx, Inc. (CDNA)

CareDx, Inc. (CDNA) is a healthcare company (diagnostics & research) based in the United States. The share price is $73.42, down 0.41% on the day, which values the company at $3.86B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.

Key facts

Share price
$73.42−0.41% today
Market value
$3.86B
P/E ratio
31.0×last 12 months
Forward P/E
46.9×
Funk Score
45/100
Against its own history
Well above its usual priceusual price $20.23
200-week average
$19.99267% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

CareDx, Inc. in more detail

CDNA trades at 31.0× its last twelve months' earnings, 46.9× next year's expected earnings, 7.8× sales. Measured against its own history, the price is 263% above what its usual multiples would imply ($20.23) — well above its usual price. It sits 267% above its 200-week average of $19.99.

Over the last five fiscal years CareDx, Inc. has compounded revenue 14.6% a year. Its Funk Score is 45 out of 100 (financial strength 8.5, profitability 2.6, growth 6.5, value 0.6, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt.

4 of the superinvestors tracked here hold CDNA, including Cathie Wood (0.6% of the portfolio), Chuck Royce (founder) (0.3% of the portfolio), Ron Baron (0.2% of the portfolio).

Superinvestors holding CDNA

4 of the investors tracked here report a position in their latest 13F filing.

CareDx, Inc. (CDNA): questions and answers

What is CDNA's P/E ratio?

CareDx, Inc. trades at 31.0× its last twelve months' earnings and 46.9× next year's expected earnings.

What is CareDx, Inc.'s market cap?

CareDx, Inc. is valued at $3.86B at a share price of $73.42.

Is CDNA overvalued or undervalued?

Against its own history, CDNA is well above its usual price: the price is 263% above the $20.23 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is CDNA above its 200-week moving average?

Yes. CDNA is 267.2% above its 200-week average of $19.99. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is CareDx, Inc. growing?

Over the last five fiscal years CareDx, Inc.'s revenue grew 14.6% a year; over ten years revenue grew 29.7% a year.

Does CDNA pay a dividend?

CareDx, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “CareDx, Inc. (CDNA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CDNA

Underlying data: Yahoo Finance; company filings with the SEC.